Ventricular Assist Devices Market
Ventricular Assist Devices Market Forecasts to 2030 - Global Analysis By Product (Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device and Total Artificial Heart), Design, Type of Flow, Application, End User and By Geography
According to Stratistics MRC, the Global Ventricular Assist Devices Market is accounted for $3.6 billion in 2024 and is expected to reach $10.7 billion by 2030 growing at a CAGR of 19.6% during the forecast period. Mechanical pumps called Ventricular Assist Devices (VADs) help the ventricles pump blood to the body, hence supporting heart function. Patients who are not candidates for transplant surgery, have significant heart failure, or are awaiting a heart transplant frequently utilize them. VADs can be inserted into one or both ventricles, the most frequent being the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD). They raise the standard of living for patients, increase blood flow, and lessen cardiac strain.
According to the American Heart Association (AHA), the prevalence of heart failure is expected to increase at a significant growth rate by 2030 in the U.S., and is projected to reach over 8 million patients. In 2020, globally, more than 5.5 million individuals were affected by heart failure. Old-age people are at high risk of HF. Therefore, the increasing geriatric population has also been fueling the disease prevalence.
Market Dynamics:
Driver:
Global prevalence of heart failure
In wealthy nations, heart failure affects 1-2% of the population; by 2030, nearly 8 million Americans may be affected, according to forecasts. The rise in heart failure instances is a major factor driving the need for VADs. Moreover chronic illnesses that are common in aging populations, such as diabetes and hypertension, are the primary cause of the rise in heart failure patients Hence the demand for VADs is increased by the scarcity of available cardiac donors.
Restraint:
Risks associated with implantation
Increased bleeding risks are one of the surgical consequences associated with VAD implants, and anticoagulant medication may make matters worse. External parts such as controllers and power supplies can act as sites of entry for infections, which can cause serious problems and higher post-transplant mortality rates. Thrombosis is one device-related consequence that requires cautious anticoagulation level monitoring because it might cause strokes or pump failure. Furthermore, right ventricular dysfunction brought on by an increased stress on the heart may complicate patient outcomes and necessitate further procedures.
Opportunity:
Continuous innovations in VAD technology
Progress in technology has resulted in more robust and compact devices, enhancing the comfort and mobility of patients. Advances in biocompatibility have lowered risks of thrombosis and infections, which has lowered obstacles to patient adoption. VAD therapy is now more widely available to a larger range of patients thanks to the less invasive nature of miniaturization, which also makes recovery times quicker and implantation processes simpler.
Threat:
Inadequate reimbursement policies and insurance coverage
VADs require implantation procedures as well as post-operative care, which can be costly. Patients may be discouraged from choosing VAD therapy if they have to pay large out-of-pocket costs due to inadequate insurance coverage. Insufficient access to care can lead to postponed or abandoned medical interventions, deteriorating health outcomes and increasing long-term healthcare expenses, ultimately decreasing market demand for VADs.
Covid-19 Impact:
The COVID-19 pandemic negatively impacted the Ventricular Assist Devices (VAD) market by causing significant delays in elective surgeries and a reduction in device utilization. Lockdowns and travel restrictions led to fewer VAD transplants, as many patients postponed seeking treatment due to safety concerns. This resulted in decreased demand for VADs, affecting revenue for manufacturers and healthcare providers. However, as restrictions eased, a rebound in patient visits and procedures is anticipated, potentially revitalizing market growth in subsequent years.
The biventricular assist devices segment is expected to be the largest during the forecast period
The biventricular assist devices segment is expected to be the largest during the forecast period owing to increased demand and advancements in BiVAD technology, such as pneumatically driven systems that improve device performance and usefulness in total artificial heart (TAH) transplant scenarios. Better hemodynamic support, improved quality of life, increased survival rates, and more patient and physician acceptance are all achieved by BiVADs.
The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period
The bridge-to-transplant segment is expected to have the highest CAGR during the forecast period owing to its vital function in keeping patients stable while they await heart transplants. VADs improve patient outcomes by providing necessary mechanical support for a period of two to six months. A greater understanding of the effectiveness of BTT therapy promotes its broader use in the treatment of heart failure.
Region with largest share:
North America is expected to have the largest market share over the projection period due to the growing rate of heart failure in North America combined with technological developments in medical devices has raised demand for valve assist devices (VADs) as destination and bridge-to-transplant therapies. Moreover VADs offer a vital substitute in the event that there are insufficient donor hearts available for transplantation, assisting patients in surviving either permanently or while they wait for a transplant.
Region with highest CAGR:
Asia Pacific is anticipated to witness the highest rate of growth during the forecast period owing to increased investment in modern medical technology and healthcare infrastructure by China, India, Japan, and South Korea is contributing to the growing use of VADs. The need for sophisticated heart failure management solutions is being driven by rising awareness and enhanced diagnostic capabilities. The Asia Pacific VAD market is expanding as a result of technological developments that include the development of smaller, more effective devices with fewer issues.
Key players in the market
Some of the key players in Ventricular Assist Devices Market include Abiomed Inc., BiVACOR Inc, Abbott Laboratories, Berlin Heart GmbH, Calon Cardio, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, Jarvik Heart Inc., ReliantHeart, Inc. and Sun Medical Technology Research Corp .
Key Developments:
In September 2024, Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness and found that while most agree that preparation has improved since the COVID-19 pandemic.
In September 2024, Abbott announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally.
In September 2024, Medtronic plc announced at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.
Products Covered:
• Left Ventricular Assist Device
• Right Ventricular Assist Device
• Biventricular Assist Device
• Total Artificial Heart
Designs Covered:
• Implantable Ventricular Assist Devices
• Transcutaneous Ventricular Assist Devices
Type of Flows Covered:
• Pulsatile Flow VAD
• Continuous Flow VAD
Applications Covered:
• Bridge-to-Transplant
• Destination Therapy
• Bridge-to-Recovery
• Bridge-to-Candidacy
End Users Covered:
• Hospitals
• Cardiac Surgery Centers
• Home Care Agencies
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Ventricular Assist Devices Market, By Product
5.1 Introduction
5.2 Left Ventricular Assist Device
5.3 Right Ventricular Assist Device
5.4 Biventricular Assist Device
5.5 Total Artificial Heart
6 Global Ventricular Assist Devices Market, By Design
6.1 Introduction
6.2 Implantable Ventricular Assist Devices
6.3 Transcutaneous Ventricular Assist Devices
7 Global Ventricular Assist Devices Market, By Type of Flow
7.1 Introduction
7.2 Pulsatile Flow VAD
7.3 Continuous Flow VAD
8 Global Ventricular Assist Devices Market, By Application
8.1 Introduction
8.2 Bridge-to-Transplant
8.3 Destination Therapy
8.4 Bridge-to-Recovery
8.5 Bridge-to-Candidacy
9 Global Ventricular Assist Devices Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Cardiac Surgery Centers
9.4 Home Care Agencies
9.5 Other End Users
10 Global Ventricular Assist Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Abiomed Inc.
12.2 BiVACOR Inc.
12.3 Abbott Laboratories
12.4 Berlin Heart GmbH
12.5 Calon Cardio
12.6 Medtronic PLC
12.7 SynCardia Systems LLC
12.8 Terumo Corporation
12.9 Jarvik Heart Inc.
12.10 ReliantHeart, Inc.
12.11 Sun Medical Technology Research Corp
List of Tables
1 Global Ventricular Assist Devices Market Outlook, By Region (2022-2030) ($MN)
2 Global Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
3 Global Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
4 Global Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
5 Global Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
6 Global Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
7 Global Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
8 Global Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
9 Global Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
10 Global Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
11 Global Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
12 Global Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
13 Global Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
14 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
15 Global Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
16 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
17 Global Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
18 Global Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
19 Global Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
20 Global Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
21 Global Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
22 Global Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
23 North America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
24 North America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
25 North America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
26 North America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
27 North America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
28 North America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
29 North America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
30 North America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
31 North America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
32 North America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
33 North America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
34 North America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
35 North America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
36 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
37 North America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
38 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
39 North America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
40 North America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
41 North America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
42 North America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
43 North America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
44 North America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
45 Europe Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
46 Europe Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
47 Europe Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
48 Europe Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
49 Europe Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
50 Europe Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
51 Europe Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
52 Europe Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
53 Europe Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
54 Europe Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
55 Europe Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
56 Europe Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
57 Europe Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
58 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
59 Europe Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
60 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
61 Europe Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
62 Europe Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
63 Europe Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
64 Europe Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
65 Europe Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
66 Europe Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
67 Asia Pacific Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
68 Asia Pacific Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
69 Asia Pacific Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
70 Asia Pacific Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
71 Asia Pacific Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
72 Asia Pacific Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
73 Asia Pacific Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
74 Asia Pacific Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
75 Asia Pacific Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
76 Asia Pacific Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
77 Asia Pacific Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
78 Asia Pacific Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
79 Asia Pacific Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
80 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
81 Asia Pacific Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
82 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
83 Asia Pacific Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
84 Asia Pacific Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
85 Asia Pacific Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
86 Asia Pacific Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
87 Asia Pacific Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
88 Asia Pacific Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
89 South America Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
90 South America Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
91 South America Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
92 South America Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
93 South America Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
94 South America Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
95 South America Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
96 South America Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
97 South America Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
98 South America Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
99 South America Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
100 South America Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
101 South America Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
102 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
103 South America Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
104 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
105 South America Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
106 South America Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
107 South America Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
108 South America Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
109 South America Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
110 South America Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
111 Middle East & Africa Ventricular Assist Devices Market Outlook, By Country (2022-2030) ($MN)
112 Middle East & Africa Ventricular Assist Devices Market Outlook, By Product (2022-2030) ($MN)
113 Middle East & Africa Ventricular Assist Devices Market Outlook, By Left Ventricular Assist Device (2022-2030) ($MN)
114 Middle East & Africa Ventricular Assist Devices Market Outlook, By Right Ventricular Assist Device (2022-2030) ($MN)
115 Middle East & Africa Ventricular Assist Devices Market Outlook, By Biventricular Assist Device (2022-2030) ($MN)
116 Middle East & Africa Ventricular Assist Devices Market Outlook, By Total Artificial Heart (2022-2030) ($MN)
117 Middle East & Africa Ventricular Assist Devices Market Outlook, By Design (2022-2030) ($MN)
118 Middle East & Africa Ventricular Assist Devices Market Outlook, By Implantable Ventricular Assist Devices (2022-2030) ($MN)
119 Middle East & Africa Ventricular Assist Devices Market Outlook, By Transcutaneous Ventricular Assist Devices (2022-2030) ($MN)
120 Middle East & Africa Ventricular Assist Devices Market Outlook, By Type of Flow (2022-2030) ($MN)
121 Middle East & Africa Ventricular Assist Devices Market Outlook, By Pulsatile Flow VAD (2022-2030) ($MN)
122 Middle East & Africa Ventricular Assist Devices Market Outlook, By Continuous Flow VAD (2022-2030) ($MN)
123 Middle East & Africa Ventricular Assist Devices Market Outlook, By Application (2022-2030) ($MN)
124 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Transplant (2022-2030) ($MN)
125 Middle East & Africa Ventricular Assist Devices Market Outlook, By Destination Therapy (2022-2030) ($MN)
126 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Recovery (2022-2030) ($MN)
127 Middle East & Africa Ventricular Assist Devices Market Outlook, By Bridge-to-Candidacy (2022-2030) ($MN)
128 Middle East & Africa Ventricular Assist Devices Market Outlook, By End User (2022-2030) ($MN)
129 Middle East & Africa Ventricular Assist Devices Market Outlook, By Hospitals (2022-2030) ($MN)
130 Middle East & Africa Ventricular Assist Devices Market Outlook, By Cardiac Surgery Centers (2022-2030) ($MN)
131 Middle East & Africa Ventricular Assist Devices Market Outlook, By Home Care Agencies (2022-2030) ($MN)
132 Middle East & Africa Ventricular Assist Devices Market Outlook, By Other End Users (2022-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
